Gluconate metabolism of Pasteurellapestis

Insights

Pasteurella pestis utilizes gluconate through two key metabolic pathways: the 6-phosphogluconate dehydrogenase-transketolase pathway and the Entner-Doudoroff pathway. This study identified essential enzymes involved in Pasteurella pestis gluconate metabolism.

Area of Science:

  • Microbiology
  • Biochemistry
  • Bacteriology

Background:

  • Pasteurella pestis is a virulent bacterium responsible for plague.
  • Understanding bacterial metabolism is crucial for developing effective treatments and control strategies.
  • Gluconate metabolism plays a role in the energy production and virulence of various microorganisms.

Purpose of the Study:

  • To investigate the gluconate metabolic pathways in a virulent strain of Pasteurella pestis.
  • To identify the key enzymes involved in gluconate degradation by Pasteurella pestis.
  • To determine the specific routes of 6-phosphogluconate metabolism.

Main Methods:

  • Preparation of cell-free extracts from Pasteurella pestis.
  • Enzymatic assays to detect the presence of specific metabolic enzymes.
  • Analysis of the degradation products of 6-phosphogluconate.

Main Results:

  • Evidence for gluconokinase, 6-phosphogluconate dehydrogenase, transketolase, and 2-keto-3-deoxy-6-phosphogluconate dehydrase in cell-free extracts.
  • 6-phosphogluconate was metabolized via both the 6-phosphogluconate dehydrogenase-transketolase and Entner-Doudoroff pathways.
  • No active glucose-6-phosphate dehydrogenase was detected.

Conclusions:

  • Pasteurella pestis employs distinct enzymatic pathways for gluconate metabolism.
  • The identified enzymes and pathways provide insights into the bacterium's metabolic capabilities.
  • Further research can explore the implications of these pathways for Pasteurella pestis virulence and survival.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...